Clinical Trials Logo

Cancer Survivors clinical trials

View clinical trials related to Cancer Survivors.

Filter by:

NCT ID: NCT03981809 Completed - Cancer Pain Clinical Trials

Screening Tool to Identify the Dominant Pain Mechanism in Cancer Survivors: PainsCan

PainsCan
Start date: June 13, 2019
Phase:
Study type: Observational [Patient Registry]

Development and internal validation of an easy-to-use tool for clinical pain assessment. The tool has to be applicable in any clinical practice and without the need for expensive and complicated hospital tools to identify the source of persistent pain after the treatment of cancer.

NCT ID: NCT03961217 Completed - Prostate Cancer Clinical Trials

Return to Work Among Cancer Survivors With Treatment-induced Survivorship Syndromes

Start date: January 1991
Phase:
Study type: Observational [Patient Registry]

The investigators plan to investigate the consequences of late effects (radiation-induced survivorship syndromes) after radiotherapy in Gynecological and Prostate cancer survivors on return to work (Yes/No) and if RTW happened then time to RTW. In addition, whether general health, type of work (occupation), work environment factors, individual factors (lifestyle, socioeconomic status etc.), contribute to the adverse late effects of radiotherapy and these Gynecological cancer survivors have a higher risk for disability pension/long term sickness absence (NOT Return to work).

NCT ID: NCT03695406 Completed - Cancer Survivors Clinical Trials

Mind Body Program for Fear of Recurrence

Start date: August 9, 2017
Phase: N/A
Study type: Interventional

This is a pilot feasibility study of a group-based, mind body intervention for managing stress and fear of recurrence and promoting resiliency among adult cancer survivors.

NCT ID: NCT03618017 Completed - Clinical trials for Breast Cancer Female

The ConnectedCancerCare Pilot Study (CCC)

CCC
Start date: August 8, 2018
Phase: N/A
Study type: Interventional

This study is an NCI-funded, randomized control pilot trial to evaluate: (1) the feasibility and acceptability of a web-based, personalized navigation tool (ConnectedCancerCare) and (2) explore whether the tool improves delivery of team-based survivorship care for women who have recently finished primary breast cancer treatment.

NCT ID: NCT03459781 Completed - Cancer Survivors Clinical Trials

Compassion Meditation for Cancer Survivor-Caregiver Dyads

Start date: March 14, 2018
Phase: Phase 1/Phase 2
Study type: Interventional

Survivors of solid tumor cancers and their informal caregivers (family, friends) experience impairments in health-related quality of life (HRQOL) including disruptions in psychological, physical, social, and spiritual well-being. Our prior work demonstrates that impairments in depression, anxiety, fatigue, and negative affect experienced by cancer survivors across time are interdependent those experienced by their informal caregivers. These findings suggest that interventions directed simultaneously toward both members of the cancer survivor-caregiver dyad may be especially impactful in improving HRQOL in cancer survivors and informal caregivers. Although a number of interventions have been developed and tested to support the survivor or the caregiver, few have attempted to simultaneously intervene with both to improve HRQOL within the collective survivor-caregiver dyad. CBCT®, Cognitively-Based Compassion Training (already piloted by members of this team with breast cancer survivors, is an 8-week manualized meditation-based program that starts with attention and mindfulness training and builds to contemplation about compassion for the self and others. The proposed pilot feasibility study builds upon this work to intervene with caregivers in addition to survivors of solid tumor cancers. The major aim of the proposed project is to test the feasibility and acceptability of CBCT® for survivors of solid tumor cancer and their informal caregivers after the end of cancer treatment. The project will also determine in a preliminary manner whether or not CBCT® (compared to a cancer health education [CHE] comparison group) has a positive impact on different measures of HRQOL (e.g. features of depression and anxiety, fatigue, social isolation), stress-related biomarkers of inflammation and cortisol, and assessments related to healthcare utilization. IMPORTANT READER NOTE: ==> A prior version of this study protocol on clinicaltrials.gov incorrectly stated information about interpretation of scores of the Morisky Medication Adherence Scale-8 (MMAS-8). ==> Individuals interested in using the MMAS-8 are directed to https://morisky.org for information about the scale, as well as for licensing and other requirements for using the MMAS-8 in their research or clinical practice. Dr. Pace and his colleagues sincerely regret any incorrect information posted previously about the MMAS-8 on this clinicaltrials.gov trial website.

NCT ID: NCT02895880 Completed - Cancer Survivors Clinical Trials

A Risk Assessment Tool to Increase Statin Use Among High Risk Cancer Survivors: Development and Pilot Testing

Start date: August 2016
Phase:
Study type: Observational

The purpose of this study is to collect initial data on what survivors of childhood, adolescent, and young adult cancer think of how information about statins is communicated. Statins are medications that lower cholesterol. The results of this study will be used to improve the communication about statins. This is to aid patients and their providers in making health care decisions together, also known as shared decision making.

NCT ID: NCT02152020 Completed - Cancer Survivors Clinical Trials

Patient-Centered Acupuncture for Pain (PCAP)

Start date: May 2014
Phase: N/A
Study type: Observational

The objective of this study is to find out if acupuncture can improve the management of pain in cancer patients when used as part of a treatment plan that includes conventional pain medications. The investigators will enroll 36 cancer patients at Abramson Cancer Center and Penn Cancer Network sites. Participants will be enrolled in either the Conventional Pain Management group or Integrative Pain Management group.

NCT ID: NCT01888523 Completed - Cancer Survivors Clinical Trials

Stress Management for Cancer Survivors

Start date: February 2014
Phase: N/A
Study type: Interventional

Determine the efficacy of a brief and inexpensive psychosocial intervention, (called expressive writing) in improving health outcomes for cancer survivors.

NCT ID: NCT01228955 Completed - Cancer Survivors Clinical Trials

Yoga Intervention for Cancer Survivors

Start date: February 2010
Phase: N/A
Study type: Observational

Impaired health related quality of life (HRQOL) including fatigue, problems with sleep and psychosocial well being (physical, emotional, and spiritual) have been noted in adult cancer survivors. Physical domain is one of the most common measured indicators of HRQOL. Despite the tremendous implications of having an impaired QOL, few studies have staged interventions aimed at improving HRQOL in a heterogeneous group of cancer survivors. There is little literature examining whether a yoga intervention is feasible in a heterogeneous group of cancer survivors. The proposed research will utilize Vanderbilt Ingram Cancer Center (VICC), Nashville General Hospital (NGH) and REACH for Survivorship program for a pilot study. The investigators will see if a study using a broad range of diagnoses is feasible for a Yoga Intervention.

NCT ID: NCT01108484 Completed - Cancer Survivors Clinical Trials

Program of Exercise, Diet and Control of Psychological Stress in Cancer Survivors

EDICOS
Start date: March 2010
Phase: N/A
Study type: Interventional

A program of exercise, diet and psycho-emotional support could improve some outcomes in cancer survivors.